1. Home
  2. HALO vs CRDO Comparison

HALO vs CRDO Comparison

Compare HALO & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • CRDO
  • Stock Information
  • Founded
  • HALO 1998
  • CRDO 2008
  • Country
  • HALO United States
  • CRDO Cayman Islands
  • Employees
  • HALO N/A
  • CRDO N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • CRDO Semiconductors
  • Sector
  • HALO Health Care
  • CRDO Technology
  • Exchange
  • HALO Nasdaq
  • CRDO Nasdaq
  • Market Cap
  • HALO 7.4B
  • CRDO 7.3B
  • IPO Year
  • HALO N/A
  • CRDO 2022
  • Fundamental
  • Price
  • HALO $48.95
  • CRDO $59.58
  • Analyst Decision
  • HALO Buy
  • CRDO Strong Buy
  • Analyst Count
  • HALO 9
  • CRDO 10
  • Target Price
  • HALO $63.56
  • CRDO $68.00
  • AVG Volume (30 Days)
  • HALO 3.0M
  • CRDO 3.8M
  • Earning Date
  • HALO 05-06-2025
  • CRDO 05-28-2025
  • Dividend Yield
  • HALO N/A
  • CRDO N/A
  • EPS Growth
  • HALO 55.40
  • CRDO N/A
  • EPS
  • HALO 3.76
  • CRDO 0.03
  • Revenue
  • HALO $1,084,306,000.00
  • CRDO $327,532,000.00
  • Revenue This Year
  • HALO $24.79
  • CRDO $125.51
  • Revenue Next Year
  • HALO $22.65
  • CRDO $58.82
  • P/E Ratio
  • HALO $13.00
  • CRDO $1,914.42
  • Revenue Growth
  • HALO 25.64
  • CRDO 99.38
  • 52 Week Low
  • HALO $41.28
  • CRDO $16.98
  • 52 Week High
  • HALO $70.51
  • CRDO $86.69
  • Technical
  • Relative Strength Index (RSI)
  • HALO 34.26
  • CRDO 73.01
  • Support Level
  • HALO $47.50
  • CRDO $45.65
  • Resistance Level
  • HALO $69.94
  • CRDO $61.44
  • Average True Range (ATR)
  • HALO 3.34
  • CRDO 2.59
  • MACD
  • HALO -1.51
  • CRDO 1.84
  • Stochastic Oscillator
  • HALO 6.30
  • CRDO 91.26

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

Share on Social Networks: